Which tests should be ordered for culture-negative infective endocarditis?

Diagnostic Testing for Culture-Negative Infective Endocarditis

For culture-negative infective endocarditis, send serological testing for Bartonella species (IgG ≥1:800) and Coxiella burnetii (phase I IgG ≥1:800), and if valve tissue becomes available, perform PCR testing (16S rRNA or specific pathogen PCR) along with histopathology. 1, 2

Algorithmic Approach to Testing

Step 1: Evaluate Epidemiological Context First

Before ordering tests, assess specific risk factors that guide which pathogens to target 1:

• Animal exposure (cats/fleas → Bartonella; farm animals → Coxiella burnetii, Brucella)
• Geographic location (Q fever endemic areas)
• Prosthetic valve timing (early vs. late PVE changes pathogen likelihood)
• Prior antibiotic exposure (reduces blood culture yield by 35-40%)

Step 2: Serological Testing (First-Line for Culture-Negative Cases)

The most common identifiable causes of culture-negative IE are fastidious organisms requiring serology 1, 3:

• Bartonella species serology: IgG titer ≥1:800 (though be aware this cutoff has limited validation and false positives can occur) 2
• Coxiella burnetii (Q fever) serology: Phase I IgG ≥1:800 (the most widely used cutoff, though based on limited data) 2
• Brucella serology: If exposure history suggests risk 1

Critical caveat: Serological testing identified pathogens in 47.7% of culture-negative cases in large reference laboratory analysis, primarily detecting Coxiella and Bartonella 1

Step 3: Molecular Testing from Valve Tissue (When Available)

If surgical intervention occurs or valve tissue is obtained 1, 3:

• Specific real-time PCR assays: Target enterococci, streptococci, Bartonella, Coxiella, Tropheryma whipplei, and Mycoplasma hominis (these increased diagnostic yield by 24.3% in one study) 3
• Broad-range 16S rRNA PCR/sequencing: Identified pathogens in two-thirds of valves studied 1, 4
• Histopathology with immunohistochemistry: Can detect organisms not identified by other methods 3

Important finding: PCR from valve tissue showed significantly greater sensitivity (P<0.01) than other methods and detected 27 additional cases (15.3%) that were missed by serology and culture 3

Step 4: Consider Fungal Testing

Blood cultures are positive in most Candida IE cases but rarely positive in Aspergillus IE, making it a true cause of culture-negative disease 1. Consider:

• Beta-D-glucan and galactomannan testing
• Fungal cultures with extended incubation if risk factors present (prosthetic valves, central lines, immunosuppression)

Step 5: Molecular Rapid Diagnostics from Blood (Emerging Role)

While not yet routinely recommended, these may be useful in select cases 2, 5:

• Cell-free DNA testing (e.g., Karius test): Can detect >1000 pathogens with 87-93% sensitivity 6
• Multiplex PCR panels: Particularly useful after antibiotic exposure
• Metagenomic sequencing: Offers untargeted detection but limited by availability and cost 5

Common Pitfalls to Avoid

1. Don't wait for negative cultures to start specialized testing: Begin serological workup early, especially if epidemiological factors suggest fastidious organisms 1

2. Don't forget non-infectious mimics: Consider testing for antiphospholipid antibodies (APA syndrome), particularly if mitral valve involvement with regurgitation and embolic phenomena 1

3. Don't rely solely on blood culture duration: Standard 5-day incubation is adequate for most IE causes; prolonged incubation only helps for Cutibacterium acnes in PVE 2

4. Don't overlook the importance of valve tissue: PCR from valve tissue detects pathogens in cases where blood testing (including serology) is negative—14 cases detected from valves only in one series 3

Strength of Evidence

The 2015 AHA guidelines provide Class I recommendations for comprehensive evaluation of culture-negative cases and infectious disease consultation 1. The 2023 Duke-ISCVID criteria now formally incorporate molecular diagnostics and expanded serological testing 7. A 2017 prospective study demonstrated that adding specific PCR assays increased diagnostic yield to 78% (from 62.7% with traditional methods), with most gains from detecting enterococci and streptococci 3.

Consultation with infectious diseases is a Class I recommendation for all culture-negative endocarditis cases 1.